In the News
VenstraMedical CEO Martin Cook discusses the ‘compelling’ company story with Steve Maxson on the MedTech Unboxed podcast…
The CSI D-HF is a niche conference conducted in Frankfurt, Germany that presents the latest in heart failure intervention therapies and is attended by clinicians, industry and investors.
VenstraMedical announces it has secured a portion of its capital raise goal from HighCroft Capital. These proceeds, when rounded out from additional investors, will accelerate development of the companies novel pVAD system.
VenstraMedical is pleased to share preclinical results of our pVAD system development at #TCT2025 presented by Dr. Suku Thambar, Chief Medical Officer…
VenstraMedical is proud to be featured in the American Society for Artificial Organs (ASAIO) Journal highlighting the pre-clinical testing of our novel pVAD platform...
The Gold Coast Cardiology Conference-Innovations in Interventions will take place from 18-20th of September in the Gold Coast, Australia. Our cofounder, Dr. Suku Thambar, is a Co-Course Director …
VenstraMedical (#LSIEurope25 Presenter) has developed what it believes to be the world’s smallest and most powerful percutaneous ventricular assist device (pVAD) …
VenstraMedical will be attending LSI Europe '25, Medtech's premier partnering event held this September in London-be sure to connect with our CEO, Martin Cook, if you are planning to attend!
There's no better validation of our development efforts at VenstraMedical than to get featured in Forbes Magazine! We are eager to get our technology to those who could benefit…
VenstraMedical is pleased to share our recent company milestone as we work towards developing a novel pVAD platform for patients suffering from Cardiogenic shock…
VenstraMedical is delighted to be participating in the Mayo Clinic Cardiology and Radiology Innovation Summit in May. We are very much looking forward to …
When it comes to mechanical circulatory support devices like pVADs one must consider pressure when evaluating the flow performance. That’s why we are proud to publicly share our test results...
VenstraMedical is developing a next-generation technology providing temporary cardiac support to the most critically ill cardiac patients. Their percutaneous catheter pump (pVAD) is…
Congratulations to VenstraMedical Co-founder, Dr. Suku Thambar, on his poster presentation at #THT2025 highlighting the superior hydraulic performance of the VenstraMedical pVAD platform!